Dancer S J
Department of Microbiology, Southern General Hospital, Glasgow G51 4TF, Scotland, UK.
J Antimicrob Chemother. 2008 Feb;61(2):246-53. doi: 10.1093/jac/dkm465. Epub 2007 Dec 5.
Antimicrobial drugs encourage the overgrowth of organisms resistant to the agents used. Acquisition and subsequent overgrowth of methicillin-resistant Staphylococcus aureus (MRSA) are particularly associated with beta-lactam antibiotics and quinolones. These drugs allow rapid proliferation of an organism that might have been merely colonizing the skin, leading to clinical infection, treatment difficulties and potential transmission to others. In addition, there is increasing evidence that inappropriate antibiotics not only encourage overgrowth with MRSA but may also enhance pathogenicity. Such virulence is not necessarily due to simple expansion of MRSA across skin and mucosal surfaces; there appear to be molecular changes that facilitate mechanisms such as quorum sensing, adhesion, phage mobilization, exotoxin production, intracellular persistence and biofilm formation, all of which contribute towards more severe infection. This review examines the association between MRSA and certain classes of antibiotics and explores the molecular mechanisms underlying a perceived increase in virulence following inappropriate therapy. It is possible that empirical prescribing has a significant impact on the management of MRSA infections and ultimately patient outcome. It is time to challenge the prescribers' right to prescribe what they like, when they like, for patients at risk of MRSA.
抗菌药物会促使对所用药物产生耐药性的微生物过度生长。耐甲氧西林金黄色葡萄球菌(MRSA)的获得及随后的过度生长尤其与β-内酰胺类抗生素和喹诺酮类药物有关。这些药物会使原本可能只是在皮肤定植的微生物迅速增殖,从而导致临床感染、治疗困难并可能传播给他人。此外,越来越多的证据表明,不恰当使用抗生素不仅会促使MRSA过度生长,还可能增强其致病性。这种毒力增强不一定仅仅是由于MRSA在皮肤和黏膜表面的简单扩散;似乎存在分子变化,促进了群体感应、黏附、噬菌体移动、外毒素产生、细胞内存活和生物膜形成等机制,所有这些都导致更严重的感染。本综述探讨了MRSA与某些种类抗生素之间的关联,并探究了不当治疗后毒力增加背后的分子机制。经验性用药可能对MRSA感染的管理以及最终的患者预后产生重大影响。现在是时候挑战开处方者为有MRSA感染风险的患者随意开处方的权利了。